Contemporary Incidence and Predictors of Occult Inguinal Lymph Node Metastases in Men With Clinically Node-negative (cN0) Penile Cancer. 2021

Pooja Unadkat, and Aaron Fleishman, and Aria F Olumi, and Andrew Wagner, and Peter Chang, and Simon P Kim, and Ruslan Korets, and Boris Gershman
Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA.

To (1) examine the contemporary incidence of occult inguinal LN metastases and (2) identify predictors of occult inguinal LN metastases to improve selection of cN0 patients for inguinal lymphadenectomy (ILND). We identified 590 men with cTany cN0 cM0 penile cancer who underwent partial/radical penectomy and ILND from 2006-2016 in the NCDB. Rates of pN+ disease were examined, and a multivariable regression model was constructed to identify features associated with pN+ disease. Tumors were ≤pT1 in 21%, pT2 in 43%, and pT3/pT4 in 24% of patients. A median of 15 (IQR 8-22) LNs were removed at ILND. The overall pN+ rate was 24% and did not vary over the study period. The pN+ rate, stratified by pT stage, varied from 18-33%. On multivariable analysis, only higher tumor grade (OR 2.16; P = 0.02 for grade 2; OR 2.81; P = 0.005 for grade 3-4, versus grade 1) and lymphovascular invasion (OR 3.12; P <0.001) were independently associated with pN+ disease, whereas pT stage was not. The contemporary rate of occult LN metastases in men with cN0 penile cancer remains high at approximately 24%. Our results suggest that high tumor grade and/or lymphovascular invasion are better determinants of lymph node involvement than primary tumor stage.

UI MeSH Term Description Entries
D007264 Inguinal Canal The tunnel in the lower anterior ABDOMINAL WALL through which the SPERMATIC CORD, in the male; ROUND LIGAMENT, in the female; nerves; and vessels pass. Its internal end is at the deep inguinal ring and its external end is at the superficial inguinal ring. Inguinal Ring,Canal, Inguinal,Canals, Inguinal,Inguinal Canals,Inguinal Rings,Ring, Inguinal,Rings, Inguinal
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010412 Penile Neoplasms Cancers or tumors of the PENIS or of its component tissues. Cancer of Penis,Penile Cancer,Cancer of the Penis,Neoplasms, Penile,Neoplasms, Penis,Penis Cancer,Penis Neoplasms,Cancer, Penile,Cancer, Penis,Cancers, Penile,Cancers, Penis,Neoplasm, Penile,Neoplasm, Penis,Penile Cancers,Penile Neoplasm,Penis Cancers,Penis Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates

Related Publications

Pooja Unadkat, and Aaron Fleishman, and Aria F Olumi, and Andrew Wagner, and Peter Chang, and Simon P Kim, and Ruslan Korets, and Boris Gershman
October 2014, Hinyokika kiyo. Acta urologica Japonica,
Pooja Unadkat, and Aaron Fleishman, and Aria F Olumi, and Andrew Wagner, and Peter Chang, and Simon P Kim, and Ruslan Korets, and Boris Gershman
June 2023, EJNMMI research,
Pooja Unadkat, and Aaron Fleishman, and Aria F Olumi, and Andrew Wagner, and Peter Chang, and Simon P Kim, and Ruslan Korets, and Boris Gershman
October 2008, Chinese medical journal,
Pooja Unadkat, and Aaron Fleishman, and Aria F Olumi, and Andrew Wagner, and Peter Chang, and Simon P Kim, and Ruslan Korets, and Boris Gershman
April 2018, Der Urologe. Ausg. A,
Pooja Unadkat, and Aaron Fleishman, and Aria F Olumi, and Andrew Wagner, and Peter Chang, and Simon P Kim, and Ruslan Korets, and Boris Gershman
January 2020, American journal of otolaryngology,
Pooja Unadkat, and Aaron Fleishman, and Aria F Olumi, and Andrew Wagner, and Peter Chang, and Simon P Kim, and Ruslan Korets, and Boris Gershman
December 2020, Translational andrology and urology,
Pooja Unadkat, and Aaron Fleishman, and Aria F Olumi, and Andrew Wagner, and Peter Chang, and Simon P Kim, and Ruslan Korets, and Boris Gershman
March 2005, The Journal of urology,
Pooja Unadkat, and Aaron Fleishman, and Aria F Olumi, and Andrew Wagner, and Peter Chang, and Simon P Kim, and Ruslan Korets, and Boris Gershman
September 2023, Urologic oncology,
Pooja Unadkat, and Aaron Fleishman, and Aria F Olumi, and Andrew Wagner, and Peter Chang, and Simon P Kim, and Ruslan Korets, and Boris Gershman
January 2019, International braz j urol : official journal of the Brazilian Society of Urology,
Pooja Unadkat, and Aaron Fleishman, and Aria F Olumi, and Andrew Wagner, and Peter Chang, and Simon P Kim, and Ruslan Korets, and Boris Gershman
June 2003, The New England journal of medicine,
Copied contents to your clipboard!